Electronic Intervention to Chronic Opioid Therapy | NCT04198961 | Trialant

Electronic Intervention to Chronic Opioid Therapy | NCT04198961 | Trialant

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Electronic Intervention	Experimental	Individualized opioid taper and safety recommendations will be communicated to prescribers via an electronic medical record encrypted message.	Other: opioid prescribing

Interventions

Name	Type	Description	Arm Group Labels	Other Names
opioid prescribing	Other	Individualized taper and safety recommendations will be communicated to prescribers via an electronic medical record encrypted message.	Electronic Intervention

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Change in the number of patients who receives naloxone prescription	Change in the number of patients who receives naloxone prescription	baseline, 1, 3- and 6-months and 12 months
change of number of documentation about safety discussions	change of number of documentation about safety discussions	baseline, 1, 3- and 6-months and 12 months
change of number of order for urine toxicology screening	change of number of order for urine toxicology screening	baseline, 1, 3- and 6-months and 12 months
change of number of documentation of prescription drug monitoring program (CURES) results	change of number of documentation of prescription drug monitoring program (CURES) results	baseline, 1, 3- and 6-months and 12 months
change of number of signed opioid informed consent forms	change of number of signed opioid informed consent forms	baseline, 1, 3- and 6-months and 12 months

Secondary Outcomes

Measure	Description	Time Frame
Change in number of patients on long-term high risk doses of opioid pain medications	decreases in daily dose of opioids and number of patients on opioids ≥ 90mg MEDD	baseline, 1, 3- and 6-months and 12 months

Contacts/Locations Module